Sen. Bernard Sanders (I-VT) and Rep. Elijah Cummings (D-MD) on Thursday (Nov. 20) introduced companion bills that would require generic drug companies pay Medicaid rebates when drug prices rises faster than inflation. The lawmakers introduced the legislation in response to unexpected price spikes for some generic drugs, but generic drug makers say public health insurance programs still save money each year from generic drugs. There are two kinds of drug rebates in the Medicaid program, a congressional aide noted. Both...